As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...

Wockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...

Domestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...

Benchmark indices experienced a negative close on Thursday, marked by volatile trade and profit booking. Analysts anticipate the Nifty to c...

Global lenders are exploring various financing options for Sun Pharmaceutical Industries' proposed $12 billion acquisition of Organon & Co....

Sun Pharma is set to nearly double its revenue to $12 billion with the acquisition of Organon, creating a global pharmaceutical giant. The ...

Sun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...

Indian enterprises are navigating challenges posed by the Goods and Services Tax. The inverted duty scenario is particularly affecting FMCG...

Uttar Pradesh State Industrial Development Authority and Jawaharlal Nehru Port Authority have partnered. This agreement aims to make the La...

Union Health Minister JP Nadda is working on a solution for the pharmaceutical industry. Drug regulator and department of pharmaceuticals a...

The Union Health Ministry is in talks with states about extending the deadline for pharmaceutical companies to meet new manufacturing quali...

The health ministry has sought a legal opinion on extending the deadline for MSMEs to comply with revised Schedule M standards. The final d...

The government is set to decide on implementing the revised Schedule M for pharmaceutical products by next week. While pharma groups have r...

Drugmakers in India may soon face stricter enforcement of quality standards. The revised Schedule M, which details manufacturing practices ...

The finance minister Nirmala Sitharaman in her budget speech said the genomics and pharmaceuticals will get supportive policies, light-touc...

The strategy of brand extensions, one of the biggest branding tools in the FMCG industry, is now finding application in the Indian pharma s...